EnteroTrack Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2M

  • Investors
  • 6

EnteroTrack General Information

Description

Developer of a non-invasive medical device designed to facilitate the diagnosis of inflammatory conditions of the gastrointestinal tract. The company's device combines a capsule that can identify the presence of esophageal inflammation for diagnosing conditions of the gastrointestinal tract, such as eosinophilic esophagitis, severe gastroesophageal reflux and bowel disease, and monitor the effectiveness of treatment, enabling medical researchers to offer a low-cost alternative for analysis of esophageal content where blood tests and radio-imaging are not able to detect the cause of inflammation.

Contact Information

Website
www.enterotrack.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12635 East Montview Boulevard
  • Aurora, CO 80045
  • United States
+1 (720)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Vertical(s)
Digital Health, E-Commerce
Corporate Office
  • 12635 East Montview Boulevard
  • Aurora, CO 80045
  • United States
+1 (720)

EnteroTrack Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EnteroTrack Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 25-Sep-2026 $2M Completed Generating Revenue
8. Accelerator/Incubator 27-Feb-2024 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
6. Grant 16-Nov-2023 Completed Generating Revenue
5. Accelerator/Incubator 26-Apr-2023 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
3. Later Stage VC (Series B) 04-Jun-2021 Completed Generating Revenue
2. Early Stage VC 01-Sep-2017 $500K $750K Completed Startup
1. Angel (individual) 08-Jul-2014 $250K $250K Completed Startup
To view EnteroTrack’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

EnteroTrack Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 7

    Pending

  • Expiring in next 12 mo

EnteroTrack Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024502113-A Apparatus, methods, and systems for sampling and analyzing the gastrointestinal tract Pending 04-Jan-2021
AU-2022205060-A1 Devices, methods and systems for sampling and analyzing the gastrointestinal tract Pending 04-Jan-2021
AU-2022205060-A9 Devices, methods and systems for sampling and analyzing the gastrointestinal tract Pending 04-Jan-2021
CA-3204028-A1 Devices, methods and systems for sampling and analyzing the gastrointestinal tract Pending 04-Jan-2021
EP-4271280-A1 Devices, methods and systems for sampling and analyzing the gastrointestinal tract Pending 04-Jan-2021 A61B10/04
To view EnteroTrack’s complete patent history, request access »

EnteroTrack Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EnteroTrack Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
CancerX (USA) Accelerator/Incubator
Creative Destruction Lab Accelerator/Incubator
Advanced Industries Accelerator Government
Colorado BioScience Association Not-For-Profit Venture Capital
Innosphere Ventures Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

EnteroTrack FAQs

  • When was EnteroTrack founded?

    EnteroTrack was founded in 2013.

  • Where is EnteroTrack headquartered?

    EnteroTrack is headquartered in Aurora, CO.

  • What is the size of EnteroTrack?

    EnteroTrack has 7 total employees.

  • What industry is EnteroTrack in?

    EnteroTrack’s primary industry is Diagnostic Equipment.

  • Is EnteroTrack a private or public company?

    EnteroTrack is a Private company.

  • What is EnteroTrack’s current revenue?

    The current revenue for EnteroTrack is .

  • How much funding has EnteroTrack raised over time?

    EnteroTrack has raised $7.41M.

  • Who are EnteroTrack’s investors?

    CancerX (USA), Creative Destruction Lab, Advanced Industries Accelerator, Colorado BioScience Association, and Innosphere Ventures are 5 of 6 investors who have invested in EnteroTrack.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process